Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (61-70 of 283) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug developmentGeorge Poste, David P Carbone, David R Parkinson, et al.
Journal of Hematology & Oncology|March 27, 2025
Recent advances in therapeutic strategies for non-small cell lung cancerPo-Lan Su, Naoki Furuya, Alahmadi Asrar, et al.
Cancer Research|November 9, 2016
A Transcriptional Signature Identifies LKB1 Functional Status as a Novel Determinant of MEK Sensitivity in Lung AdenocarcinomaJacob M Kaufman, Tadaaki Yamada, Kyungho Park, et al.
Cancer Research|January 7, 2006
Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancerIldiko Csiki, Kiyoshi Yanagisawa, Nobuhiro Haruki, et al.
Cancer Research|September 7, 2007
Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancersJun Konishi, Keiko S Kawaguchi, Huan Vo, et al.
Journal of Clinical Medicine|December 10, 2021
Linear Endobronchial Ultrasound in the Era of Personalized Lung Cancer Diagnostics-A Technical ReviewFiliz Oezkan, Stephan Eisenmann, Kaid Darwiche, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 18, 2011
Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer modelsYunguang Sun, Luigi Moretti, Nicholas J Giacalone, et al.
Neoplasia (New York, N.Y.)|August 1, 2022
Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapyShuxiao Guan, Shankar Suman, Joseph M Amann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
A double-blind randomized discontinuation phase-II study of sorafenib (BAY 43-9006) in previously treated non-small-cell lung cancer patients: eastern cooperative oncology group study E2501Heather A Wakelee, Ju-Whei Lee, Nasser H Hanna, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2009
Genetic and proteomic features associated with survival after treatment with erlotinib in first-line therapy of non-small cell lung cancer in Eastern Cooperative Oncology Group 3503Joseph M Amann, Ju-Whei Lee, Heinrich Roder, et al.
Pageof 29

Showing results (61-70 of 283) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug developmentGeorge Poste, David P Carbone, David R Parkinson, et al.
Journal of Hematology & Oncology|March 27, 2025
Recent advances in therapeutic strategies for non-small cell lung cancerPo-Lan Su, Naoki Furuya, Alahmadi Asrar, et al.
Cancer Research|November 9, 2016
A Transcriptional Signature Identifies LKB1 Functional Status as a Novel Determinant of MEK Sensitivity in Lung AdenocarcinomaJacob M Kaufman, Tadaaki Yamada, Kyungho Park, et al.
Cancer Research|January 7, 2006
Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancerIldiko Csiki, Kiyoshi Yanagisawa, Nobuhiro Haruki, et al.
Cancer Research|September 7, 2007
Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancersJun Konishi, Keiko S Kawaguchi, Huan Vo, et al.
Journal of Clinical Medicine|December 10, 2021
Linear Endobronchial Ultrasound in the Era of Personalized Lung Cancer Diagnostics-A Technical ReviewFiliz Oezkan, Stephan Eisenmann, Kaid Darwiche, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 18, 2011
Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer modelsYunguang Sun, Luigi Moretti, Nicholas J Giacalone, et al.
Neoplasia (New York, N.Y.)|August 1, 2022
Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapyShuxiao Guan, Shankar Suman, Joseph M Amann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
A double-blind randomized discontinuation phase-II study of sorafenib (BAY 43-9006) in previously treated non-small-cell lung cancer patients: eastern cooperative oncology group study E2501Heather A Wakelee, Ju-Whei Lee, Nasser H Hanna, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2009
Genetic and proteomic features associated with survival after treatment with erlotinib in first-line therapy of non-small cell lung cancer in Eastern Cooperative Oncology Group 3503Joseph M Amann, Ju-Whei Lee, Heinrich Roder, et al.
Pageof 29